Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence.

González CA, Sanz-Anquela JM, Gisbert JP, Correa P
Int J Cancer. 2013 133 (5): 1023-32

PMID: 23280711 · PMCID: PMC3732516 · DOI:10.1002/ijc.28003

MeSH Terms (9)

Biomarkers Cross-Sectional Studies Follow-Up Studies Humans Intestines Metaplasia Precancerous Conditions Risk Stomach Neoplasms

Connections (2)

This publication is referenced by other Labnodes entities: